Eutilex.Co.,Ltd (KOSDAQ:263050)
959.00
+221.00 (29.95%)
At close: Feb 6, 2026
Eutilex.Co.,Ltd Revenue
Eutilex.Co.,Ltd had revenue of 3.53B KRW in the quarter ending September 30, 2025, a decrease of -9.36%. This brings the company's revenue in the last twelve months to 10.54B, up 52.93% year-over-year. In the year 2024, Eutilex.Co.,Ltd had annual revenue of 9.53B with 7,136.10% growth.
Revenue (ttm)
10.54B
Revenue Growth
+52.93%
P/S Ratio
3.35
Revenue / Employee
n/a
Employees
n/a
Market Cap
35.32B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kainos Medicine | 938.87M |
| Epibiotech | 449.62M |
| SCM Lifescience | 1.54B |
| ADBiotech | 14.57B |
| J2KBIO | 31.12B |
| MOA Life Plus | 9.80B |
| NGeneBio | 9.98B |
| EyeGene | 4.10B |